Related Experiment Video

Updated: Oct 6, 2025

Stem Cell-Derived Viral Ag-Specific T Lymphocytes Suppress HBV Replication in Mice
07:25

Stem Cell-Derived Viral Ag-Specific T Lymphocytes Suppress HBV Replication in Mice

Published on: September 25, 2019

7.0K

[Antiviral therapy and clinical cure for chronic hepatitis B in children: progress and challenges]

M Zhang1, J Li2, F S Wang3

  • 1Department of Liver Diseases, The Fifth Medical Center of Chinese PLA General Hospital, National Clinical Research Center for Infectious Diseases, Beijing 100039, China.

Zhonghua Gan Zang Bing Za Zhi = Zhonghua Ganzangbing Zazhi = Chinese Journal of Hepatology
|January 20, 2022
PubMed

Insights

Antiviral treatment for chronic hepatitis B in children is a growing concern. This review examines current strategies, focusing on treatment decisions, regimens, and outcomes to inform adult treatment approaches.

Area of Science:

  • Hepatology
  • Pediatric Infectious Diseases
  • Virology

Background:

  • Chronic hepatitis B is a significant global health issue.
  • Pediatric antiviral treatment for chronic hepatitis B is gaining attention.
  • Understanding treatment efficacy and safety in children is crucial.

Purpose of the Study:

  • To review the current status and progress of antiviral therapy for chronic hepatitis B in children.
  • To analyze key treatment considerations including indication, timing, and regimens.
  • To explore factors contributing to the clinical cure of chronic hepatitis B in pediatric patients.

Main Methods:

  • Literature review of current research on pediatric chronic hepatitis B antiviral treatment.
  • Analysis of treatment guidelines, efficacy data, and safety profiles.
  • Exploration of factors influencing treatment outcomes and clinical cure.

Main Results:

  • Current antiviral treatments for chronic hepatitis B in children are evolving.
  • Treatment decisions require careful consideration of individual patient factors.
  • Efficacy and safety data guide optimal therapeutic strategies.

Conclusions:

  • Evidence-based treatment strategies are essential for managing pediatric chronic hepatitis B.
  • Further research is needed to optimize antiviral therapies for children.
  • Findings may inform future treatment protocols for adult chronic hepatitis B.

Keywords:
Antiviral therapyChildrenChronic hepatitis BClinical cure

More Related Videos

A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target11:34

A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target

Published on: May 10, 2022

2.4K
Author Spotlight: Advancements and Challenges in Hepatitis B Virus Detection04:11

Author Spotlight: Advancements and Challenges in Hepatitis B Virus Detection

Published on: December 15, 2023

3.9K

Related Concept Videos

Retrovirus Life Cycles01:10

Retrovirus Life Cycles

Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the...
47.3K
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
11
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
17
Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
452